PURE Bioscience, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- PURE Bioscience, Inc. (OTCQB: PURE) develops and commercializes proprietary antimicrobial products based on patented Silver Dihydrogen Citrate (SDC), a broad-spectrum, non-toxic agent stabilized with ionic silver, targeting pathogen and hygienic control challenges in health, environmental, and food safety applications; the company manufactures and distributes EPA-registered SDC-based disinfectants and sanitizers such as PURE Hard Surface, PURE Control produce wash, and membrane cleaning solutions for food-contact surfaces, equipment, and multi-surface use in food processing facilities; it also supplies SDC formulations as raw material ingredients to manufacturers of personal care products. Products feature low EPA toxicity ratings, no-rinse requirements, fast kill times against pathogens including Salmonella, Listeria, E. coli, and Norovirus, non-corrosive properties, minimal residue, and wastewater safety, with applications in dairy membrane treatment to reduce fouling, extend membrane life, and minimize downtime. Founded in 1992 and headquartered in El Cajon, California, the company primarily serves the food and beverage industry, including processors, restaurants, dairy plants, and produce operations, with geographic focus on the United States and regulatory registrations from the EPA, FDA, and Health Canada. In recent developments, PURE Bioscience expanded its distribution network through a multi-year agreement with Hydrite Chemical Company in January 2025 for food processing and dairy markets, following an eight-year relationship; it formed a strategic partnership with Bonsai in fiscal 2025 fourth quarter to enable direct-to-customer sales of SDC sanitizers and disinfectants via online platform; core business revenue grew 14% in the fiscal year ended July 31, 2025, amid development of membrane treatment technology for dairy and beverage sectors and ongoing R&D collaborations.
Skyharbour Signs Definitive Agreement with Purecore to Option its Yurchison Uranium Property in the Athabasca Basin
Skyharbour Signs Letter of Intent with Purecore to Option its Yurchison Uranium Property in the Athabasca Basin
HONEYWELL TECHNOLOGIES LAUNCHES AS INDEPENDENT, PURE-PLAY AUTOMATION COMPANY FOLLOWING COMPLETION OF HONEYWELL AEROSPACE SPIN-OFF
PURE Bioscience Reports Fiscal Third Quarter 2026 Financial Results
Purecore Strengthens Technical Advisory Expertise with Nuclear Fuel Cycle and Uranium Enrichment Specialist, Ted Rygas, PhD
Purecore Announces up to $1.5 Million Non-Brokered Private Placement
Purecore Announces Listing on the Frankfurt Stock Exchange
Purecore Metals Announces Field Program Commencement at the Bankier Property
Purecore Engages HEG & Associates for its 2026 Exploration Program at the Bankier Property
Purecore Metals Inc. Announces Listing on the Canadian Securities Exchange Under the Symbol “PURE”
Caliber and PURE Pickleball & Padel Announce Building Permit Approval for World's Largest Indoor Pickleball and Padel Facility
PURE Bioscience Reports Fiscal Second Quarter 2026 Financial Results
Reviewing Green Thumb Industries (OTCMKTS:GTBIF) and PURE Bioscience (OTCMKTS:PURE)
Contrasting Agilent Technologies (NYSE:A) & PURE Bioscience (OTCMKTS:PURE)
PURE Property Management and HomeRiver Group Merge, Secure $80 Million in Growth Capital
PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results
PURE Bioscience, Inc. Announces Leadership Promotions
CORVEX TO GO PUBLIC IN ALL-STOCK MERGER WITH MOVANO, CREATING A PURE-PLAY PLATFORM FOR SECURE AI INFRASTRUCTURE AND HIGH-PERFORMANCE INFERENCE
PURE Bioscience (OTCMKTS:PURE) Sees Significant Drop in Short Interest
PURE Bioscience Reports Fiscal 2025 Financial Results